Cargando…

PB2422: PATIENTS WITH HIGH EBV VIRAL LOAD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATE GOOD PROGNOSIS WHEN RAPID IMMUNOSUPPRESSANTS DOSE REDUCTION CAN BE ACHIEVED

Detalles Bibliográficos
Autores principales: Tsushima, Takafumi, Masuda, Shin-Ichi, Yoda, Natsumi, Kainuma, Sayaka, Tanaka, Kazusuke, Shimoji, Sonoko, Kimura, Kenji, Arai, Hironori, Utsu, Yoshikazu, Imadome, Ken-Ichi, Aotsuka, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429201/
http://dx.doi.org/10.1097/01.HS9.0000976396.98302.2d
_version_ 1785090651390476288
author Tsushima, Takafumi
Masuda, Shin-Ichi
Yoda, Natsumi
Kainuma, Sayaka
Tanaka, Kazusuke
Shimoji, Sonoko
Kimura, Kenji
Arai, Hironori
Utsu, Yoshikazu
Imadome, Ken-Ichi
Aotsuka, Nobuyuki
author_facet Tsushima, Takafumi
Masuda, Shin-Ichi
Yoda, Natsumi
Kainuma, Sayaka
Tanaka, Kazusuke
Shimoji, Sonoko
Kimura, Kenji
Arai, Hironori
Utsu, Yoshikazu
Imadome, Ken-Ichi
Aotsuka, Nobuyuki
author_sort Tsushima, Takafumi
collection PubMed
description
format Online
Article
Text
id pubmed-10429201
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104292012023-08-17 PB2422: PATIENTS WITH HIGH EBV VIRAL LOAD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATE GOOD PROGNOSIS WHEN RAPID IMMUNOSUPPRESSANTS DOSE REDUCTION CAN BE ACHIEVED Tsushima, Takafumi Masuda, Shin-Ichi Yoda, Natsumi Kainuma, Sayaka Tanaka, Kazusuke Shimoji, Sonoko Kimura, Kenji Arai, Hironori Utsu, Yoshikazu Imadome, Ken-Ichi Aotsuka, Nobuyuki Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429201/ http://dx.doi.org/10.1097/01.HS9.0000976396.98302.2d Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Tsushima, Takafumi
Masuda, Shin-Ichi
Yoda, Natsumi
Kainuma, Sayaka
Tanaka, Kazusuke
Shimoji, Sonoko
Kimura, Kenji
Arai, Hironori
Utsu, Yoshikazu
Imadome, Ken-Ichi
Aotsuka, Nobuyuki
PB2422: PATIENTS WITH HIGH EBV VIRAL LOAD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATE GOOD PROGNOSIS WHEN RAPID IMMUNOSUPPRESSANTS DOSE REDUCTION CAN BE ACHIEVED
title PB2422: PATIENTS WITH HIGH EBV VIRAL LOAD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATE GOOD PROGNOSIS WHEN RAPID IMMUNOSUPPRESSANTS DOSE REDUCTION CAN BE ACHIEVED
title_full PB2422: PATIENTS WITH HIGH EBV VIRAL LOAD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATE GOOD PROGNOSIS WHEN RAPID IMMUNOSUPPRESSANTS DOSE REDUCTION CAN BE ACHIEVED
title_fullStr PB2422: PATIENTS WITH HIGH EBV VIRAL LOAD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATE GOOD PROGNOSIS WHEN RAPID IMMUNOSUPPRESSANTS DOSE REDUCTION CAN BE ACHIEVED
title_full_unstemmed PB2422: PATIENTS WITH HIGH EBV VIRAL LOAD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATE GOOD PROGNOSIS WHEN RAPID IMMUNOSUPPRESSANTS DOSE REDUCTION CAN BE ACHIEVED
title_short PB2422: PATIENTS WITH HIGH EBV VIRAL LOAD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATE GOOD PROGNOSIS WHEN RAPID IMMUNOSUPPRESSANTS DOSE REDUCTION CAN BE ACHIEVED
title_sort pb2422: patients with high ebv viral load after allogeneic hematopoietic stem cell transplantation associate good prognosis when rapid immunosuppressants dose reduction can be achieved
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429201/
http://dx.doi.org/10.1097/01.HS9.0000976396.98302.2d
work_keys_str_mv AT tsushimatakafumi pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved
AT masudashinichi pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved
AT yodanatsumi pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved
AT kainumasayaka pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved
AT tanakakazusuke pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved
AT shimojisonoko pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved
AT kimurakenji pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved
AT araihironori pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved
AT utsuyoshikazu pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved
AT imadomekenichi pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved
AT aotsukanobuyuki pb2422patientswithhighebvviralloadafterallogeneichematopoieticstemcelltransplantationassociategoodprognosiswhenrapidimmunosuppressantsdosereductioncanbeachieved